WHO Pharmacovigilance Toolkit

The new WHO PV Toolkit comprises resources and information for the practice of pharmacovigilance, with a special focus on low- and middle-income countries. Read more

30th World AIDS Day

From WHO: On 1 December 2018, WHO will join global partners to commemorate World AIDS Day under the theme “Know Your Status”. This will also be an occasion to celebrate the 30th anniversary of World AIDS Day – a pioneering ... Read more

Launching the CHAIN Network

The Childhood Acute Illness & Nutrition (CHAIN) Network brings together a network of clinical scientists to build the evidence base to help undernourished children survive, thrive and grow during and after an acute illness. Read more


Global Health Social Science

The value of an embedded qualitative study in a trial of a second antidepressant for people who had not responded to one antidepressant: understanding the perspectives of patients and general practiti

by Carolyn A. Chew-Graham, Thomas Shepherd, Heather Burroughs, Katie Dixon, David Kessler

  Background Depression is the leading cause of disability worldwide, and is a major contributor to the overall global burden of disease. The number of prescriptions for antidepressants has risen ...

Global Health Social Science

On the Evolving World of What Constitutes Qualitative Synthesis

by Sally Thorne

  ABSTRACT: As the body of available qualitatively derived knowledge expands, there is increasing temptation to capitalize on it to generate knowledge synthesis products. Concurrently, in the wake of an ...

Global Health Social Science

Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trials

by Frances C. Sherratt, Louise Roper, Simon R. Stones, Flora McErlane, Matthew Peak, Michael W. Beresford, Helen Foster, Athimalaipet V. Ramanan, Madeleine Rooney, Eileen Baildam, Bridget Young

  Background Patient recruitment can be very challenging in paediatric studies, especially in relatively uncommon conditions, such as juvenile idiopathic arthritis (JIA). However, involving children and young people (CYP) in ...